Canadian collaboration to accelerate development of cancer treatments - NRC and CCAB invest over $1M to advance innovative therapies first discovered at UofT
NRC and CCAB invest over $1M to advance innovative therapies first discovered at UofTToronto, ON – An innovative collaboration between government, industry, and academia aims to accelerate the development of cancer treatments in Canada. The National Research Council of Canada (NRC) and the Toronto-based Centre for the Commercialization of Antibodies and Biologics (CCAB) have put […]